Interviews

Dr. Mark Fendrick, MD, Professor of Medicine and Health Management and Policy, Schools of Medicine and Public Health, University of Michigan, Co-Editor-in-Chief, The American Journal of Managed Care, says that there are levers organizations and stakeholders can pull to achieve the goal of improving quality and value in cancer care.

Gary Owens, MD, Gary Owens Associates, says that trends in rheumatoid arthritis (RA) management are coming from the new 2012 American College of Rheumatology guidelines that call for earlier and more aggressive treatment of new patients as well as patients who are not doing well on existing therapies.

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Mark McClellan, MD, PhD, director, Engelberg Center for Health Care Reform, Leonard D. Schaeffer Chair in Health Policy Studies, Brookings Institution, says that getting the best possible benefits of the healthcare system at the lowest cost is what really matters to patients.

Gail Wilensky, PhD, senior fellow, Project Hope, says that larger payers are introducing plans that reward consumers for choosing high-quality healthcare clinicians with lower co-payments and premiums. Dr Wilensky also says that there are many attempts to slow spending and improve quality.

Jacque Sokolov, MD, President, CEO, SSB Solutions, says that in order for clinically integrated organizations to drive revenue the clinical and business models must be coordinated, so incentives exist for revenue enhancement and expense control.

Brian Carlin, MD, FCCP, Allegheny General Hospital, discusses the challenges in reducing 30-day readmission rates, specifically as they apply to congestive heart failure, pneumonia, and COPD. The biggest challenge of all is setting up a coordinated team care effort, says Dr Carlin.

In this video, Barbara Troupin, MD, MBA, talks about managing goals for obesity treatment. "The goal for obesity treatment is the ability to lose enough weight [to the point where] you actually are addressing the underlying pathophysiology," says Dr Troupin. She goes on to discuss the ideal percentage of weight loss necessary to lose excess adipose tissue.

Robert Berenson, MD, FACP, Institue Fellow, Health Policy Center, Urban Institute, states that the development of new care delivery models will not happen overnight. There is time before expectations are put into specific quality metrics and regulations for models such as patient-centered medical homes and accountable care organizations.

Sara Rosenbaum, JD, Harold and Jane Hirsh Professor of Health Law and Policy and Founding Chair, Department of Health Policy, George Washington University School of Public Health and Health Services, says that the purpose of health reform was to provide people a source of affordable coverage so everyone would be attached to a payment system.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo